You have nailed it in one traderci - we have a very smart CEO in Silviu.Novartis wanted more out of the deal than Silviu was prepared to give - simple as that. Silviu knows what he has in his stable and that is why he will be in the not-too-distant future the CEO of a top-two ranked market capitalized Aussie biotech!
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-186
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23545 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 339479 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |